Get the Stockscreener App
3.12
0.64%
-0.02
After Hours:
3.12
Serina Therapeutics Inc stock is traded at $3.12, with a volume of 13,105.
It is down -0.64% in the last 24 hours and down -22.39% over the past month.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
See More
Previous Close:
$3.14
Open:
$3.24
24h Volume:
13,105
Relative Volume:
0.50
Market Cap:
$33.27M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.00%
1M Performance:
-22.39%
6M Performance:
-47.34%
1Y Performance:
-33.62%
1-Day Range:
$3.119
$3.29
1-Week Range:
$3.119
$3.46
52-Week Range:
$3.119
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Name
Serina Therapeutics Inc
Sector
Industry
Phone
(256) 327-9630
Address
601 GENOME WAY, HUNTSVILLE
Compare SER with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
3.12 | 33.49M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
Serina Therapeutics Inc Stock (SER) Latest News
Serina Therapeutics CSO Moreadith sells $11,519 in stock By Investing.com - Investing.com South Africa
Serina Therapeutics CSO Moreadith sells $11,519 in stock - Investing.com
Serina Therapeutics Holds 2025 Annual Stockholders Meeting - MSN
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry - The Manila Times
Serina Therapeutics (NYSE American: SER) appoints Dr. Joshua Thomas VP, Head of Chemistry - Stock Titan
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program - The Manila Times
Serina Therapeutics (NYSE American: SER) responds to FDA clinical hold, targets Q1 2026 SER-252 Phase 1b start - Stock Titan
Serina Therapeutics Submits Response to FDA for SER-252 Program - TradingView — Track All Markets
Serina Therapeutics (NYSE: SER) files complete FDA hold response for SER-252 Parkinson's program - Stock Titan
Is Serina Therapeutics Inc. stock a defensive play amid uncertaintyWall Street Watch & Verified Momentum Watchlists - Newser
Will Serina Therapeutics Inc. stock sustain bullish trend into 2025Earnings Miss & Fast Gain Stock Trading Tips - Newser
How strong is Serina Therapeutics Inc. stock earnings growthJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser
How Serina Therapeutics Inc. stock moves in volatile trading sessionsWeekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
How Serina Therapeutics Inc. (2BO) stock valuation compares with sectorM&A Rumor & Weekly High Conviction Ideas - Newser
Will Serina Therapeutics Inc. stock profit from fiscal stimulusCEO Change & Verified Short-Term Plans - Newser
Serina Therapeutics CSO Moreadith sells $23k in shares By Investing.com - Investing.com Canada
Why Serina Therapeutics Inc. (2BO) stock benefits from AI revolutionMarket Risk Summary & Capital Efficient Trading Techniques - Newser
Will Serina Therapeutics Inc. stock hit analyst forecastsJuly 2025 Levels & Verified Swing Trading Watchlist - Newser
Why Serina Therapeutics Inc. stock is favored by hedge funds2025 Pullback Review & Risk Controlled Daily Plans - Newser
Why Serina Therapeutics Inc. stock appears on watchlistsJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Is Serina Therapeutics Inc. (2BO) stock cheap vs fundamentals2025 Fundamental Recap & Low Risk Growth Stock Ideas - Newser
Serina Therapeutics (SER) Stock Analysis Report | Financials & Insights - Benzinga
Why analysts raise outlook for Serina Therapeutics Inc. (2BO) stockPortfolio Return Summary & Risk Controlled Stock Pick Alerts - Newser
Is Serina Therapeutics Inc 2BO a good long term investmentRSI Overbought/Oversold & Fast Profit Trading Tips - earlytimes.in
What analysts say about Serina Therapeutics Inc stockFlag and Pennant Patterns & Get Trading Help From Experienced Users - earlytimes.in
What drives Serina Therapeutics Inc stock priceFundamental Stock Analysis & Market-Leading Growth Rates - earlytimes.in
Serina Therapeutics CSO Sells Shares - TradingView
Officer Moreadith Sells 5,965 ($23.3K) Of Serina Therapeutics Inc [SER] - TradingView
Serina Therapeutics insider exercises options, sells 5,965 SER shares - Stock Titan
Serina Therapeutics CSO Moreadith sells $2.1k in shares By Investing.com - Investing.com Nigeria
Serina Therapeutics CSO Moreadith sells $2.1k in shares - Investing.com
Serina Therapeutics Form 4 shows CSO option exercise and sale - Stock Titan
Officer Moreadith Sells 535 ($2.1K) Of Serina Therapeutics Inc [SER] - TradingView
Will Serina Therapeutics Inc. (2BO) stock outperform Dow JonesQuarterly Market Review & Consistent Profit Trading Strategies - newser.com
Will Serina Therapeutics Inc. stock see insider buyingMarket Movement Recap & Smart Investment Allocation Tips - newser.com
Will Serina Therapeutics Inc. (2BO) stock keep high P E multiplesDividend Hike & Safe Capital Growth Plans - newser.com
How Serina Therapeutics Inc. stock benefits from tech adoption2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Why Serina Therapeutics Inc. (2BO) stock trades below fair value2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Can Serina Therapeutics Inc. stock maintain growth trajectoryInsider Buying & Comprehensive Market Scan Insights - newser.com
Why Serina Therapeutics Inc. stock could be next big winner2025 Institutional Moves & Real-Time Volume Analysis - newser.com
Is Serina Therapeutics Inc. stock suitable for passive index fundsWeekly Stock Summary & Expert Curated Trade Setup Alerts - newser.com
Technical signs of recovery in Serina Therapeutics Inc.Portfolio Profit Report & Breakout Confirmation Alerts - newser.com
Should I buy Serina Therapeutics Inc. stock before earnings seasonIPO Watch & Low Drawdown Investment Strategies - newser.com
Moreadith of Serina Therapeutics sells shares worth $24,401 - Investing.com India
Serina Therapeutics Inc Stock (SER) Financials Data
There is no financial data for Serina Therapeutics Inc (SER). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Cap:
|
Volume (24h):